Envisagenics
AI-powered RNA therapeutics.
Overview
Envisagenics has developed SpliceCore®, a cloud-based AI drug discovery platform that uses machine learning to identify new drug targets by analyzing RNA splicing. The platform integrates genomic data with machine learning algorithms to discover disease-specific splicing errors and identify novel therapeutic targets. They are focused on developing treatments for cancer and genetic diseases.
✨ Key Features
- SpliceCore® AI platform
- RNA splicing analysis
- Target discovery
- Biomarker identification
- Focus on oncology and genetic diseases
🎯 Key Differentiators
- Specific focus on RNA splicing as a source of new drug targets.
- SpliceCore® platform with a large database of splicing events.
- Combination of AI with deep expertise in RNA biology.
Unique Value: Unlocks a new class of drug targets by using AI to understand and target RNA splicing.
🎯 Use Cases (4)
✅ Best For
- Has established collaborations with major pharmaceutical companies like Bristol Myers Squibb and Biogen.
💡 Check With Vendor
Verify these considerations match your specific requirements:
- NA
🏆 Alternatives
Focuses on a specific and important area of biology (RNA splicing) that is often overlooked by other platforms.
💻 Platforms
🔌 Integrations
🛟 Support Options
- ✓ Email Support
- ✓ Dedicated Support (Enterprise tier)
💰 Pricing
Free tier: NA
🔄 Similar Tools in AI for Drug Discovery
Atomwise
Utilizes deep learning for structure-based drug discovery to find small molecule hits....
Insilico Medicine
An end-to-end AI-driven drug discovery platform covering target identification, molecule generation,...
Recursion Pharmaceuticals
Industrializes drug discovery by combining automated biology with artificial intelligence....
Schrödinger
Provides a physics-based software platform for molecular discovery and design....
Valo Health
A technology company using human-centric data and AI to transform drug discovery and development....
BenevolentAI
Applies AI and machine learning to analyze biomedical information and accelerate drug discovery....